|
Aug 20
|
Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?
|
|
Aug 20
|
3 Stocks I Will "Never" Sell
|
|
Aug 18
|
AARP urges courts to keep drug pricing talks on track
|
|
Aug 18
|
Kenvue Is a Timely Stock
|
|
Aug 18
|
Medical device at heart of $16.6B J&J acquisition recalled
|
|
Aug 18
|
J&J’s Swap Offer for Kenvue Is About to Expire. Proration Figure Will Be Key.
|
|
Aug 18
|
Tylenol Litigation Could Be a Headache for Kenvue
|
|
Aug 10
|
UPDATE 2-US FDA approves Johnson & Johnson's blood cancer therapy
|
|
Aug 10
|
The Zacks Analyst Blog Highlights PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy
|
|
Aug 10
|
3 Top Biotech Stocks Defying the Bear Market
|
|
Aug 10
|
Disney, Capri, Sonos, Wynn Resorts rise premarket; Tapestry, Penn fall
|
|
Aug 10
|
Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock.
|
|
Aug 9
|
Kenvue Set to Join S&P 500
|
|
Aug 9
|
Johnson & Johnson's Talc Problems Aren't Going Away
|
|
Aug 9
|
5 Defensive Stocks for Stable Returns Amid Recent Volatility
|
|
Aug 9
|
A Bull Market Is Coming: 2 Warren Buffett Stocks to Buy and Hold Forever
|
|
Aug 9
|
22 Highest Paid Medical Specialties in the World
|
|
Aug 9
|
3 No-Brainer Stocks to Buy With $200 Right Now
|
|
Aug 8
|
J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know
|
|
Aug 8
|
Perrigo (PRGO) Beats on Q2 Earnings & Sales, Reiterates '23 View
|